SEPTIN2 and laryngeal squamous cell carcinoma: Reportes have indicated that FGD5‐AS1 overexpression increases cisplatin resistance in laryngeal squamous cell carcinoma (LSCC) by sponging miR‐497‐5p and upregulating septin 2 (SEPT2) [71].